Major Drug Distributors to Pay $300M Over Opioid Epidemic Claims

Three major U.S. drug distributors have agreed to pay $300 million to settle claims with health insurers and benefit plans for their role in the opioid crisis. The settlement involves McKesson Corp, Cencora Inc, and Cardinal Health Inc, and awaits approval from a federal court in Cleveland, Ohio.

Three major U.S. drug distributors have reached a $300 million settlement to address claims that they played a significant role in fueling the opioid epidemic. The settlement was revealed in court papers filed on Friday, and it involves McKesson Corp, Cencora Inc, and Cardinal Health Inc.

The proposed class action settlement was disclosed in a court filing in Cleveland, Ohio. It resolves claims by health insurers and benefit plans seeking accountability for the opioid crisis. However, the settlement still requires approval from a federal judge to proceed.

This agreement marks a significant financial commitment from the drug distributors to address the widespread impact of opioid addiction across the United States.

(With inputs from agencies.)